Phase II Study of Sipuleucel-T and Indoximod for Patients With Refractory Metastatic Prostate Cancer
Clinical trial NCT01560923 · COMPLETED
Trial details
- NCT number
- NCT01560923
- Sponsor
- Masonic Cancer Center, University of Minnesota
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2012-10-01
- Primary completion
- 2018-12-12
- Enrollment
- 47
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.